| 中文别名 |
卡博替尼;卡博替尼;Cabozantinib (XL184, BMS-907351) 抑制剂;Cabozantinib标准品;N-(4-(6,7-二甲氧基喹啉-4-基氧基)苯基)-N-(4-氟苯基)环丙烷-1,1-二羧酰胺;XL184（博卡替尼）;XL184（卡博替尼）靶向药;XL184（卡博替尼）粉末;XL184（卡博替尼）固体状;XL184,卡博替尼;卡巴唑替尼;卡博替尼 XL184;卡博替尼 cabozantinib;卡博替尼（CABOZANTINIB）;卡博替尼苹果酸盐;卡博替尼中间体;科研实验XL184（卡博替尼）;临床实验XL184;苹果酸盐;苹果酸盐Cabozantinib,XL-184;医药级XL184（卡博替尼）;N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺;博卡替尼;卡赞替尼;苹果酸盐CABOZANTINIB杀菌原材料;苹果酸盐CABXL-184;鑫源顺 卡博替尼;卡波替尼杂质 |
| 英文别名 |
XL184;Cabozantinib (XL184, BMS-907351);1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-;1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;C28H24FN3O5;Cabozantinib;Cabozantinib (XL184,BMS 907351,Cometriq®);Cabozantinib S-malate;Cabozantinib, XL184;N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;XL-180;XL-184;XL184 Cabozantinib;[14C]-Cabozantinib;BMS907351;BMS-907351;Cometriq;cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide;N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Cabozantinib Impurity;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)- (9CI);N′-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (ACI);1-N-[4-(6,7-Dimethoxyquinolin-4-yl)oxyphenyl]-1-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;BMS 907351;Cabometyx;XL 184 |
微信公众号
客服
